Akamine H, Takasu N, Komiya I, Ishikawa K, Shinjyo T, Nakachi K, Masuda M
Second Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.
Clin Endocrinol (Oxf). 1996 Oct;45(4):461-6. doi: 10.1046/j.1365-2265.1996.741562.x.
Human T-lymphotrophic virus type I (HTLV-I) is a retrovirus that causes adult T-cell leukaemia (ATL). This virus is associated with a variety of autoimmune disorders. The possible association between HTLV-I Infection and autoimmune thyroiditis has not been fully studied. We therefore evaluated anti-thyroid peroxidase antibodies (TPOAb) and anti-thyroglobulin antibodies (TGAb) in the sera of patients with ATL, carriers of HTLV-I, and in healthy control subjects to investigate the possible association between such infection and auto-immune thyroiditis.
Fifty-two ATL patients (21 males, 31 females; mean age 56.4 years) and 50 HTLV-I carriers (18 males, 32 females; mean age 56.7 years) were studied. The control subjects were 877 healthy adults (271 males, 606 females; mean age 54.8 years) who were negative for HTLV-I antibody. TPOAb, TGAb, thyroxine (T4) and thyrotrophin (TSH) were measured in serum using a radioimmunoassay kit.
Positivity for thyroid autoantibodies (TPOAb and/or TGAb) was found in 21 of 52 ATL patients (40.4%), 15 of 50 HTLV-I carriers (30.0%), and 120 of 877 control subjects (13.7%). The difference between the HTLV-I-Infected and the control subjects was statistically significant (P < 0.005). Female control subjects had a significantly higher prevalence of positivity for thyroid autoantibodies than the males (17.3 vs 5.5%, P < 0.001). Carriers of HTLV-I and patients with ATL of each sex showed an equally high prevalence of positivity for thyroid autoantibodies. Of the subjects who were positive for thyroid autoantibody, 7.5% of control subjects, 19.0% of ATL patients, and 40.0% of HTLV-I carriers had hypothyroidism. A significant difference in this respect was noted between the HTLV-I infected subjects and the control subjects (P < 0.005).
This study demonstrates a high prevalence of positivity for thyroid autoantibodies (TPOAb and/ or TGAb) in the adult T-cell leukaemia patients and the HTLV-I carriers. The adult T-cell leukaemia patients and the HTLV-I carriers each had a high prevalence of hypothyroidism. There was an association between HTLV-I infection and autoimmune thyroiditis.
人类嗜T淋巴细胞病毒I型(HTLV-I)是一种导致成人T细胞白血病(ATL)的逆转录病毒。该病毒与多种自身免疫性疾病相关。HTLV-I感染与自身免疫性甲状腺炎之间的可能关联尚未得到充分研究。因此,我们评估了ATL患者、HTLV-I携带者以及健康对照者血清中的抗甲状腺过氧化物酶抗体(TPOAb)和抗甲状腺球蛋白抗体(TGAb),以研究这种感染与自身免疫性甲状腺炎之间的可能关联。
研究了52例ATL患者(男21例,女31例;平均年龄56.4岁)和50例HTLV-I携带者(男18例,女32例;平均年龄56.7岁)。对照者为877名健康成年人(男271例,女606例;平均年龄54.8岁),其HTLV-I抗体检测为阴性。使用放射免疫分析试剂盒检测血清中的TPOAb、TGAb、甲状腺素(T4)和促甲状腺激素(TSH)。
52例ATL患者中有21例(40.4%)甲状腺自身抗体(TPOAb和/或TGAb)呈阳性,50例HTLV-I携带者中有15例(30.0%)呈阳性,877名对照者中有120例(13.7%)呈阳性。HTLV-I感染者与对照者之间的差异具有统计学意义(P < 0.005)。女性对照者甲状腺自身抗体阳性率显著高于男性(17.3%对5.5%,P < 0.001)。HTLV-I携带者和各性别ATL患者的甲状腺自身抗体阳性率均同样较高。在甲状腺自身抗体阳性的受试者中,对照者中有7.5%、ATL患者中有19.0%、HTLV-I携带者中有40.0%患有甲状腺功能减退症。HTLV-I感染者与对照者在这方面存在显著差异(P < 0.005)。
本研究表明,成人T细胞白血病患者和HTLV-I携带者中甲状腺自身抗体(TPOAb和/或TGAb)阳性率较高。成人T细胞白血病患者和HTLV-I携带者的甲状腺功能减退症患病率均较高。HTLV-I感染与自身免疫性甲状腺炎之间存在关联。